ORL

Original Paper

Middle Ear Mucosa in Chronic Effusions

(With 1 color plate)

Palva T. · Mäkinen J. · Rinne J.

Author affiliations

Helsinki University, Central Hospital, Helsinki, Finland

Related Articles for ""

ORL 1981;43:241–247

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: October 21, 1980
Accepted: November 10, 1980
Published online: January 07, 2010
Issue release date: 1981

Number of Print Pages: 7
Number of Figures: 0
Number of Tables: 0

ISSN: 0301-1569 (Print)
eISSN: 1423-0275 (Online)

For additional information: https://www.karger.com/ORL

Abstract

Biopsies of the middle ear mucosa were performed in 11 patients receiving their first ventilation tubes and in 5 patients who were admitted for reinsertion of tubes for chronic mucoid effusion. All patients had had the disease for at least 6 months. Mucosubstances were seen in the form of a mucus blanket, and as positive staining in the apical parts of the epithelial cells. Goblet cells varied greatly in frequency and larger subepithelial glands were present in cases of longer duration and intermittent discharge. In the majority of specimens, mononuclear cells were frequent in the propria, forming lymphocyte follicles in some cases. One-third of the specimens showed distinct fibrotic changes, and only a few inflammatory cells were present. Thus, mucosal response consisted of immune cells and could be due to chronic irritation, caused by bacteria and their immune complexes. Polymorphonuclear leukocytes were not present except in the effusion itself, a circumstance which points to infection as the causative factor. Pronounced proprial changes may indicate irreversibility of the disease.

© 1981 S. Karger AG, Basel




Related Articles:


Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: October 21, 1980
Accepted: November 10, 1980
Published online: January 07, 2010
Issue release date: 1981

Number of Print Pages: 7
Number of Figures: 0
Number of Tables: 0

ISSN: 0301-1569 (Print)
eISSN: 1423-0275 (Online)

For additional information: https://www.karger.com/ORL


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP